TNYA
NASDAQ
US
Tenaya Therapeutics, Inc. - Common Stock
$0.70
▲ +$0.01
(+2.06%)
Vol 1.5M
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$154.0M
ROE
-95.6%
D/E
0.00
Beta
3.21
52W
$0–$2
Wall Street Consensus
14 analysts · Apr 20264
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
92.9%
Buy Rating
Price Chart
Similar Stocks
CNTB
Connect Biopharma Holdings Ltd
$157.6M
NKTX
Nkarta Inc
$131.4M
ABOS
Acumen Pharmaceuticals Inc
$127.8M
VTVT
vTv Therapeutics Inc
$167.1M
KALA
KALA BIO Inc
$12.2M
HRTX
Heron Therapeutics Inc
$238.4M
IMUX
Immunic Inc
$64.2M
UNCY
Unicycive Therapeutics Inc
$124.0M
DTIL
Precision BioSciences Inc
$100.1M
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.12 | $-0.12 | +$0.00 |
| Sep 2025 | $-0.15 | $-0.12 | +$0.03 |
| Jun 2025 | $-0.26 | $-0.14 | +$0.12 |
| Mar 2025 | $-0.19 | $-0.24 | $-0.05 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -94.2% | -93.8% | -93.8% | -93.8% | -95.6% | -95.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 6.00 | 6.00 | 6.00 | 6.00 | 4.64 | 4.64 |
Key Ratios
ROA (TTM)
-76.9%
P/B
1.2
EPS (TTM)
$-0.79
CF/Share
$-1.73
52W High
$2.35
52W Low
$0.36
$0.36
52-Week Range
$2.35
How does TNYA compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
TNYA valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.2
▼
50%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
TNYA profitability vs Biotechnology peers
ROE
-95.6%
▼
42%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-76.9%
▼
65%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
TNYA financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
4.6
▲
4%
above
peers
(4.4)
vs Peers
vs Industry
In line
Beta
3.2
▲
231%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
TNYA fundamentals radar
TNYA
Peer median
Industry
TNYA profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
TNYA vs peers: key metrics
Latest News
No related news yet